Department of Surgery, Johns Hopkins Medical Institutes, Baltimore, Md.
Division of Vascular Surgery, Johns Hopkins Hospital, Baltimore, Md.
J Vasc Surg. 2014 Jan;59(1):159-64. doi: 10.1016/j.jvs.2013.06.084. Epub 2013 Nov 5.
Acute mesenteric ischemia (AMI) is a commonly fatal result of inadequate bowel perfusion that requires immediate evaluation by both vascular and general surgeons. Treatment often involves vascular repair as well as bowel resection and the possible need for parenteral nutrition. Little data exist regarding the rates of bowel resection following endovascular vs open repair of AMI.
Using the National Inpatient Sample database, admissions from 2005 through 2009 were identified according to International Classification of Diseases, Ninth Revision codes correlating to both AMI (557.0) and subsequent vascular intervention (39.26, 38.16, 38.06, 39.9, 99.10). Patients with a diagnosis of AMI but no intervention or nonemergent admission status were excluded. Patient level data regarding age, gender, and comorbidities were also examined. Outcome measures included mortality, length of stay, the need for bowel resection (45.6, 45.71-9, 45.8), or infusion of total parenteral nutrition (TPN; 99.10) during the same hospitalization. Statistical analysis was conducted by χ(2) tests and Wilcoxon rank-sum comparisons.
Of 23,744 patients presenting with AMI, 4665 underwent interventional treatment from 2005 through 2009. Of these patients, 57.1% were female, and the mean age was 70.5 years. A total of 679 patients underwent vascular intervention; 514 (75.7%) underwent open surgery and 165 (24.3%) underwent endovascular treatment overall during the study period. The proportion of patients undergoing endovascular repair increased from 11.9% of patients in 2005 to 30.0% in 2009. Severity of comorbidities, as measured by the Charlson index, did not differ significantly between the treatment groups. Mortality was significantly more commonly associated with open revascularization compared with endovascular intervention (39.3% vs 24.9%; P = .01). Length of stay was also significantly longer in the patient group undergoing open revascularization (12.9 vs 17.1 days; P = .006). During the study time period, 14.4% of patients undergoing endovascular procedures required bowel resection compared with 33.4% for open revascularization (P < .001). Endovascular repair was also less commonly associated with requirement for TPN support (13.7% vs 24.4%; P = .025).
Endovascular intervention for AMI had increased significantly in the modern era. Among AMI patients undergoing revascularization, endovascular treatment was associated with decreased mortality and shorter length of stay. Furthermore, endovascular intervention was associated with lower rates of bowel resection and need for TPN. Further research is warranted to determine if increased use of endovascular repair could improve overall and gastrointestinal outcomes among patients requiring vascular repair for AMI.
急性肠系膜缺血(AMI)是由于肠灌注不足导致的常见致命后果,需要血管外科和普通外科医生立即进行评估。治疗通常涉及血管修复以及肠切除术和可能需要肠外营养。关于血管内修复与开放修复 AMI 后肠切除术的比率,几乎没有数据。
使用国家住院患者样本数据库,根据国际疾病分类,第九版代码,将 2005 年至 2009 年的住院患者识别为 AMI(557.0)和随后的血管介入(39.26、38.16、38.06、39.9、99.10)。排除了有 AMI 诊断但无干预或非紧急入院状态的患者。还检查了患者的年龄、性别和合并症等数据。主要观察指标包括死亡率、住院时间、肠切除术(45.6、45.71-9、45.8)或总肠外营养(TPN;99.10)的需要。采用 χ(2)检验和 Wilcoxon 秩和比较进行统计学分析。
在 23744 例 AMI 患者中,2005 年至 2009 年有 4665 例接受介入治疗。这些患者中,57.1%为女性,平均年龄为 70.5 岁。共有 679 例患者接受血管介入治疗;514 例(75.7%)行开放手术,165 例(24.3%)行血管内治疗。血管内修复的比例从 2005 年的 11.9%增加到 2009 年的 30.0%。严重程度,用 Charlson 指数衡量,两组之间没有明显差异。与血管内介入治疗相比,开放性再血管化的死亡率明显更高(39.3%比 24.9%;P=0.01)。接受开放再血管化治疗的患者住院时间也明显更长(12.9 比 17.1 天;P=0.006)。研究期间,14.4%的血管内手术患者需要肠切除术,而开放再血管化的比例为 33.4%(P<0.001)。血管内修复也较少需要 TPN 支持(13.7%比 24.4%;P=0.025)。
AMI 的血管内介入治疗在现代时代显著增加。在接受血管再通的 AMI 患者中,血管内治疗与死亡率降低和住院时间缩短有关。此外,血管内介入与较低的肠切除术和 TPN 需求相关。需要进一步研究以确定 AMI 血管修复患者中血管内修复的使用增加是否可以改善整体和胃肠道结局。